Chronic Kidney Disease

Dinesh Khullar , Anish Kumar Gupta , Kulwant Singh

Read time: 21m 40s

Laibah Arshad Khan , Adeena Jamil , Stephen J Greene , et al

Read time: 37m 48s
AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s
AHA 24 Late-Breaking Discussion: REALIZE-K

Harriette Van Spall, Mikhail Kosiborod

Watch time: 22m 30s
EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease

William Herrington

Watch time: 8m 11s

Aleksandra Bykova , Maria Serova , Maria Chashkina , et al

Read time: 22m 11s
EASD 24: Prespecified Analysis from the SELECT Trial

Helen Colhoun

Watch time: 5m 37s
ESC 24: FINE-HEART: Finerenone in HF & CKD

Muthiah Vaduganathan

Watch time: 4m 24s
ADA 24: FLOW Trial: Kidney Outcomes in Patients Treated with Semaglutide

Vlado Perkovic

Watch time: 5m 40s
Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s

Clara Bonanad Lozano , Anjay Rastogi

HFA 24: FINE-HEART: Design & Baseline Characteristics

Muthiah Vaduganathan

Watch time: 4m 40s

Muthiah Vaduganathan

Sydney Tang et al

Clara Bonanad Lozano , Anjay Rastogi

Andrew JS Coats, Stefan Anker

Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s

Shelley Zieroth et al

Watch time: 20m 16s (3 videos)

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Navdeep Tangri, James Burton, David Wheeler et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
Optimising RAASi Management in Cardiorenal Patients

Andrew Frankel, Shelley Zieroth, , et al

Watch time: 1h 7m 6s

James Burton

Paul Kalra

Watch time: 12m 41s (2 videos)

Andrew Frankel, Shelley Zieroth et al

Media

CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)
Heart Failure in Focus Podcast - Ep 6: Cardiorenal Care in Practice

Muthiah Vaduganathan, ,

Listen time: 20m 40s

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day Two

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day One

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Paul Kalra

Watch time: 12m 41s (2 videos)
ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s

Andrew JS Coats, Stefan Anker

Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s

Shelley Zieroth et al

Watch time: 20m 16s (3 videos)

Media

Shelley Zieroth et al

Watch time: 20m 16s (3 videos)
Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s
ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s

Paul Kalra

Watch time: 12m 41s (2 videos)
HFA 24: Timing of Cardio-Kidney Protection with SGLT2i

Muthiah Vaduganathan

Watch time: 5m 24s
ESC 24: FINE-HEART: Finerenone in HF & CKD

Muthiah Vaduganathan

Watch time: 4m 24s
AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s

Broadcast

Heart Failure

Prevention & Chronic Conditions
Optimising RAASi Management in Cardiorenal Patients

Andrew Frankel, Shelley Zieroth, , et al

Watch time: 1h 7m 6s

Andrew Frankel, Shelley Zieroth et al

EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease

William Herrington

Watch time: 8m 11s
AHA 24 Late-Breaking Discussion: REALIZE-K

Harriette Van Spall, Mikhail Kosiborod

Watch time: 22m 30s

Andrew JS Coats, Stefan Anker

Articles

Finerenone: Will It Be a Game-changer?

Dinesh Khullar

,

Anish Kumar Gupta

,

Kulwant Singh

,

Published:

23 December 2024

Citation:

Cardiac Failure Review 2024;10:e19.

DOI:

https://doi.org/10.15420/cfr.2024.11
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 3203
  • Downloads: Downloads 207
  • Read time: 21m 40s

Aldosterone and Potassium in Heart Failure

Laibah Arshad Khan

,

Adeena Jamil

,

Stephen J Greene

,

Muhammad Shahzeb Khan

,

Javed Butler

,

Published:

20 December 2024

Citation:

Cardiac Failure Review 2024;10:e18.

DOI:

https://doi.org/10.15420/cfr.2024.09
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1718
  • Downloads: Downloads 172
  • Read time: 37m 48s

GLP-1RA in Different HFpEF Phenotypes

Aleksandra Bykova

,

Maria Serova

,

Maria Chashkina

,

Raisa Kosharnaya

,

Zukhra Salpagarova

,

Denis Andreev

,

Ilya Giverts

,

Published:

16 October 2024

Citation:

Cardiac Failure Review 2024;10:e14.

DOI:

https://doi.org/10.15420/cfr.2024.06
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1693
  • Downloads: Downloads 176
  • Read time: 22m 11s